Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aytu BioPharma, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AYTU
Nasdaq
2830
aytubio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aytu BioPharma, Inc.
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
- Jan 6th, 2025 2:00 pm
Aytu BioPharma Proposes Settlement in Shareholder Lawsuit
- Dec 5th, 2024 11:32 am
Aytu BioPharma Disclosure Notification
- Dec 4th, 2024 4:45 am
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)
- Nov 22nd, 2024 2:00 pm
Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations
- Nov 16th, 2024 1:31 pm
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ...
- Nov 14th, 2024 7:16 am
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
- Nov 13th, 2024 9:05 pm
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
- Nov 6th, 2024 10:20 pm
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
- Oct 14th, 2024 8:15 pm
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
- Oct 1st, 2024 12:00 pm
Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations
- Sep 28th, 2024 12:49 pm
Q4 2024 Aytu Biopharma Inc Earnings Call
- Sep 27th, 2024 11:40 am
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
- Sep 26th, 2024 8:15 pm
Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
- Sep 19th, 2024 9:30 pm
Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long
- Sep 8th, 2024 1:44 pm
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
- Aug 8th, 2024 9:20 pm
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
- Aug 6th, 2024 12:00 pm
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
- Jul 17th, 2024 11:00 am
It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year
- Jun 19th, 2024 10:48 am
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
- Jun 18th, 2024 12:00 pm
Scroll